Beta: Sign in
Shares outstandingAs of 2026-08-10 · filed common shares: 25.40M
Shares float: Sign in
Float %: Sign in
Insider ownershipDirectors and officers, from their latest Form 3/4/5 holding: 7.61%
Institutional ownership: Sign in
Short interestShare of shares outstanding, at settlement: 0.28%
Short ratioDays to cover, as published by FINRA: 1.32
Short volume (5D)Share of FINRA reporting-facility volume sold short, daily flow: 33.80%
Short volume (20D)Share of FINRA reporting-facility volume sold short, daily flow: 31.50%
Avg volume (10D)

See the full stock page

Prices, charts, ranges, valuation ratios, dividends, momentum and analyst estimates are licensed for signed-in members. A free account opens every stock, fund and crypto page.

Create free account

Source: SEC filings. Information and analytics, not investment advice.

Rev growth (fwd)

Avg volume (3 months)

Profitability

Gross margin: —
Operating margin (nine months)Nine months: 2025-01-01 to 2025-09-30 · Not annualized: -13703.85%
Net margin: —
EBITDA margin (nine months)Nine months: 2025-01-01 to 2025-09-30 · Not annualized: -13666.15%
Return on equityNet income (TTM to Jun 26) ÷ average shareholders equity: -206.26%
Return on assetsNet income (TTM to Jun 26) ÷ average total assets: -121.85%

Growth

Revenue growth (annual YoY): 132.14%
Revenue growth (latest qtr YoY): -100.00%
Revenue growth (fwd): Sign in
Net income growth (annual YoY): —
Net income growth (latest qtr YoY): —
EPS growth (fwd): Sign in
Net income growth (QoQ): —

Valuation

Market cap: Sign in
Enterprise value: Sign in
P/E: Sign in
P/E (fwd): Sign in
PEG: Sign in
PEG (fwd): Sign in
Price / book: Sign in
Price / sales

Price / operating cash flow

P/FCF

EV / revenue

EV / EBITDA

EPSDiluted, TTM to Jun 26

-1.87

EPS (fwd)

Financial health

Cash & equivalentsas of Jun 26: $23.02M
Total cash: Sign in
Total debtBorrowings + finance and operating lease liabilities, as of Sep 25: $3.19M
Debt / equityas of Sep 25: 181.76%
Current ratioas of Jun 26: 6.65
Quick ratio: —
Operating cash flowTTM to Jun 26: -$21.13M
Free cash flowUnadjusted FCF = CFO − capex · TTM to Jun 26: -$21.20M
TTM revenue / diluted shareDiluted, TTM to Jun 26: 0.00

SER stock Statistics — Serina Therapeutics, Inc. filings, insiders & smart money · Instaport